{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:14:19Z","timestamp":1648818859520},"reference-count":9,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.2967\/jnumed.117.200527","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T18:20:30Z","timestamp":1512670830000},"page":"610-611","source":"Crossref","is-referenced-by-count":1,"title":["Immuno-PET in Pontine Glioma: More Than Meets the Eye?"],"prefix":"10.2967","volume":"59","author":[{"given":"Wim J.G.","family":"Oyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"key":"2021051712115473000_59.4.610.1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0269-0","article-title":"Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics","volume":"4","author":"Hoffman","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"2021051712115473000_59.4.610.2","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1038\/ncomms11185","article-title":"Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma","volume":"7","author":"Nikbakht","year":"2016","journal-title":"Nat Commun."},{"key":"2021051712115473000_59.4.610.3","first-page":"1615","article-title":"Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy","volume":"59","author":"Steffens","year":"1999","journal-title":"Cancer Res."},{"key":"2021051712115473000_59.4.610.4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv577"},{"key":"2021051712115473000_59.4.610.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.078030"},{"key":"2021051712115473000_59.4.610.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.197897"},{"key":"2021051712115473000_59.4.610.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.05.026"},{"key":"2021051712115473000_59.4.610.8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature."},{"key":"2021051712115473000_59.4.610.9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","article-title":"Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma","volume":"170","author":"Qin","year":"2017","journal-title":"Cell."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.200527","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:27:33Z","timestamp":1621283253000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.200527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":9,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,2]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.2967\/jnumed.117.200527"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.200527","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]}}}